Sort   by:  
 Page size 
UnknownEvaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models.
Not available
S-EPMC8494364 | biostudies-literature
UnknownPharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP).
Not available
S-EPMC4166693 | biostudies-literature
UnknownLong-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.
Not available
S-EPMC7001333 | biostudies-literature
UnknownSubcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study.
Not available
S-EPMC6714075 | biostudies-literature
UnknownMatching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.
Not available
S-EPMC12308543 | biostudies-literature
UnknownExposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema.
Not available
S-EPMC5869560 | biostudies-literature
Sort   by:  
 Page size